Author: Tom Wilemon
Early-onset CRC germline genetic differences identified by race, ethnicity
Jun. 15, 2023—A Vanderbilt study that delved into genetic predisposition for early-onset colorectal cancer by race and ethnicity has identified differing germline risk variants.
Enhanced treatment helps fast nicotine metabolizers quit smoking
Jun. 8, 2023—A study from Vanderbilt researchers has found that enhanced treatment support can help smokers who have more difficulty quitting because they are fast metabolizers of nicotine.
Study discovers that tumor mutation burden predicts survival outcome
Jun. 5, 2023—The expected course of a patient's cancer prognosis has traditionally been judged by its type, stage and microscopic aggressiveness, but patients with the same presentation can still have widely divergent outcomes. Researchers from Vanderbilt-Ingram Cancer Center have discovered that differences in tumor mutation burden are a major reason for this divergence.
Liquid biopsy test may detect early-stage and low DNA-shedding cancers
May. 31, 2023—Vanderbilt research shows that a liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers.
Lovly elected to American Association for Cancer Research board
May. 11, 2023—Christine Lovly, MD, PhD, has been elected to the American Association for Cancer Research board of directors.
Genomic analysis of SCLC tumors reveals subtypes, offers cues toward personalized treatments
May. 11, 2023—The largest genomic analysis ever conducted of small cell lung cancer tumors (SCLC) has identified genetic subtypes and provided insights into the mechanisms of this aggressive and deadly cancer.
Trial combines novel therapies for head and neck cancer
Apr. 27, 2023—Vanderbilt is launching a clinical trial that pairs an experimental vaccine with an established immunotherapy for recurrent, human papilloma virus (HPV)-related oropharyngeal cancer of the head and neck.
VICC Scientific Retreat focuses on emerging technologies
Apr. 26, 2023—The Vanderbilt-Ingram Cancer Center 24th Annual Scientific Retreat will be held from 8:30 am to 3 pm, May 23, in the Vanderbilt Student Life Center.
National Cancer Institute honors Berlin’s contributions, leadership
Apr. 6, 2023—Vanderbilt's Jordan Berlin, MD, is a 2022 recipient of the National Cancer Institute Director’s Award.
New treatment helps mitigate hair loss for chemotherapy patients
Mar. 30, 2023—Vanderbilt-Ingram Cancer Center has started offering scalp cooling, which mitigates hair loss for patients receiving certain chemotherapy regimens.
Sandler named co-chair of ACR’s Lung Cancer Screening Steering Committee
Mar. 30, 2023—Vanderbilt's Kim Sandler, MD, has been named co-chair of the Lung Cancer Screening Steering Committee for the American College of Radiology.
Soothing sounds
Mar. 16, 2023—Nashville pianist Ed Bazel, founder of The River of Calm music channel, recently played for patients in the waiting room of the Henry-Joyce Cancer Clinic at Vanderbilt-Ingram Cancer Center.
